Publications
5674 Results
- Journal / Conference
- ASCO 2010 Genitourinary Cancers Symposium, abstr. #274; oral
- Year
- 2010
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Do mixed histologic features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
- Journal / Conference
- Journal of Clinical Oncology 28:7s (suppl; abstr CRA4504); oral presentation
- Year
- 2010
- Research Committee(s)
- Genitourinary
- Study Number(s)
- JPR3
Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therappy (RT) in locally advanced prostate cancer (CAP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)
- Journal / Conference
- Journal of Clinical Oncology 28:7s (suppl; abstr 4024) poster
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/E2204
ECOG 2204: An intergroup phase II study of cetuxamab (Ce) or bevacizumab (B) in combination with gemcitabine (G) and in combination with capecitabine (Ca) and radiation (XRT) as adjuvant therapy (Adj Tx) for patients (pts) with completely resected pancreatic adenocarcinoma (PC)
- Journal / Conference
- Journal of Clinical Oncology 28:7s(suppl; abstr 8504); oral presentation
- Year
- 2010
- Research Committee(s)
- Melanoma
- Study Number(s)
- E4697
E4697: Phase III cooperative group study of yeast-derived granulocyte macrophage colony-stimulating factor (GM-CSF) versus placebo as adjuvant treatment of patients with completely resected stage III-IV melanoma
- Journal / Conference
- Journal of Thoracic Oncology, Nov; 5(11):1835-1840;
- Year
- 2010
- Research Committee(s)
- Lung
- PMID
- PMID20881645
- PMC
- PMC3676180
- Study Number(s)
- S0435
Sorafenib in patients with platinum treated extensive stage small cell lung cancer (SCLC): A Southwest Oncology Group (SWOG 0435) phase II trial
- Journal / Conference
- Society of Neuro-Oncology 2010 Annual Scientific Meeting; poster presentation
- Year
- 2010
- Research Committee(s)
- Brain
- Study Number(s)
- S9811
Objective response rate of unresectable benign meningioma to hydroxyurea: Southwest Oncology Group phase II trial S9811
- Journal / Conference
- British Journal of Haematology, Dec; 151(5):430-434;
- Year
- 2010
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0530
Southwest Oncology Group study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukemia [PMID21113977; PMC3058291]
- Journal / Conference
- Journal of Clinical Oncology 28(7):1209-1214
- Year
- 2010
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences [PMC2834471; PMID20085933]
- Journal / Conference
- Lancet Oncology 11(4):315
- Year
- 2010
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
In the interest of full disclosure - author's reply [correspondence] [PMID20359663]
- Journal / Conference
- Cancer 116(4):957-966
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- C89803